American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. "The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems," Johanna Mercier, the chief commercial officer of Gilead Sciences said on Monday.from IndiaTV World: Google News Feed https://ift.tt/3dTZBwf
No comments:
Post a Comment